Janus Henderson Group’s Vir Biotechnology VIR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $491K | Buy |
54,789
+17,732
| +48% | +$141K | ﹤0.01% | 2013 |
|
|
2025
Q4 | $223K | Hold |
37,057
| – | – | ﹤0.01% | 2316 |
|
|
2025
Q3 | $212K | Hold |
37,057
| – | – | ﹤0.01% | 2325 |
|
|
2025
Q2 | $187K | Hold |
37,057
| – | – | ﹤0.01% | 2334 |
|
|
2025
Q1 | $248K | Hold |
37,057
| – | – | ﹤0.01% | 2289 |
|
|
2024
Q4 | $271K | Hold |
37,057
| – | – | ﹤0.01% | 2296 |
|
|
2024
Q3 | $277K | Hold |
37,057
| – | – | ﹤0.01% | 2300 |
|
|
2024
Q2 | $330K | Sell |
37,057
-456
| -1% | -$4.37K | ﹤0.01% | 2164 |
|
|
2024
Q1 | $380K | Buy |
37,513
+5
| +0% | +$51 | ﹤0.01% | 2132 |
|
|
2023
Q4 | $377K | Sell |
37,508
-57
| -0.2% | -$521 | ﹤0.01% | 2118 |
|
|
2023
Q3 | $352K | Buy |
37,565
+14
| +0% | +$200 | ﹤0.01% | 2111 |
|
|
2023
Q2 | $921K | Sell |
37,551
-165
| -0.4% | -$4.14K | ﹤0.01% | 1650 |
|
|
2023
Q1 | $878K | Buy |
37,716
+24,522
| +186% | +$627K | ﹤0.01% | 1708 |
|
|
2022
Q4 | $334K | Sell |
13,194
-13,196
| -50% | -$323K | ﹤0.01% | 1927 |
|
|
2022
Q3 | $510K | Buy |
26,390
+13,027
| +97% | +$331K | ﹤0.01% | 1936 |
|
|
2022
Q2 | $340K | Buy |
13,363
+281
| +2% | +$6.56K | ﹤0.01% | 2000 |
|
|
2022
Q1 | $336K | Buy |
13,082
+22
| +0.2% | +$653 | ﹤0.01% | 2149 |
|
|
2021
Q4 | $547K | Sell |
13,060
-29,003
| -69% | -$1.14M | ﹤0.01% | 1841 |
|
|
2021
Q3 | $1.83M | Buy |
+42,063
| New | +$1.82M | ﹤0.01% | 1270 |
|
|
2020
Q3 | – | Sell |
-950,310
| Closed | -$38.9M | – | 1363 |
|
|
2020
Q2 | $38.9M | Buy |
+950,310
| New | +$31.9M | 0.02% | 557 |
|
Other funds holding VIR
AVM
SIAU
VPM
GP
VCM
ACM